338 related articles for article (PubMed ID: 23028781)
1. Sirt5 deacylation activities show differential sensitivities to nicotinamide inhibition.
Fischer F; Gertz M; Suenkel B; Lakshminarasimhan M; Schutkowski M; Steegborn C
PLoS One; 2012; 7(9):e45098. PubMed ID: 23028781
[TBL] [Abstract][Full Text] [Related]
2. Kinetic and Structural Basis for Acyl-Group Selectivity and NAD(+) Dependence in Sirtuin-Catalyzed Deacylation.
Feldman JL; Dittenhafer-Reed KE; Kudo N; Thelen JN; Ito A; Yoshida M; Denu JM
Biochemistry; 2015 May; 54(19):3037-3050. PubMed ID: 25897714
[TBL] [Abstract][Full Text] [Related]
3. Role of the Substrate Specificity-Defining Residues of Human SIRT5 in Modulating the Structural Stability and Inhibitory Features of the Enzyme.
Yu J; Haldar M; Mallik S; Srivastava DK
PLoS One; 2016; 11(3):e0152467. PubMed ID: 27023330
[TBL] [Abstract][Full Text] [Related]
4. The bicyclic intermediate structure provides insights into the desuccinylation mechanism of human sirtuin 5 (SIRT5).
Zhou Y; Zhang H; He B; Du J; Lin H; Cerione RA; Hao Q
J Biol Chem; 2012 Aug; 287(34):28307-14. PubMed ID: 22767592
[TBL] [Abstract][Full Text] [Related]
5. Chemical probing of the human sirtuin 5 active site reveals its substrate acyl specificity and peptide-based inhibitors.
Roessler C; Nowak T; Pannek M; Gertz M; Nguyen GT; Scharfe M; Born I; Sippl W; Steegborn C; Schutkowski M
Angew Chem Int Ed Engl; 2014 Sep; 53(40):10728-32. PubMed ID: 25111069
[TBL] [Abstract][Full Text] [Related]
6. Function and regulation of the mitochondrial sirtuin isoform Sirt5 in Mammalia.
Gertz M; Steegborn C
Biochim Biophys Acta; 2010 Aug; 1804(8):1658-65. PubMed ID: 19766741
[TBL] [Abstract][Full Text] [Related]
7. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5.
Schlicker C; Gertz M; Papatheodorou P; Kachholz B; Becker CF; Steegborn C
J Mol Biol; 2008 Oct; 382(3):790-801. PubMed ID: 18680753
[TBL] [Abstract][Full Text] [Related]
8. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase.
Du J; Zhou Y; Su X; Yu JJ; Khan S; Jiang H; Kim J; Woo J; Kim JH; Choi BH; He B; Chen W; Zhang S; Cerione RA; Auwerx J; Hao Q; Lin H
Science; 2011 Nov; 334(6057):806-9. PubMed ID: 22076378
[TBL] [Abstract][Full Text] [Related]
9. Investigating the Sensitivity of NAD+-dependent Sirtuin Deacylation Activities to NADH.
Madsen AS; Andersen C; Daoud M; Anderson KA; Laursen JS; Chakladar S; Huynh FK; Colaço AR; Backos DS; Fristrup P; Hirschey MD; Olsen CA
J Biol Chem; 2016 Mar; 291(13):7128-41. PubMed ID: 26861872
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin.
Schuetz A; Min J; Antoshenko T; Wang CL; Allali-Hassani A; Dong A; Loppnau P; Vedadi M; Bochkarev A; Sternglanz R; Plotnikov AN
Structure; 2007 Mar; 15(3):377-89. PubMed ID: 17355872
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of carba-NAD and the structures of its ternary complexes with SIRT3 and SIRT5.
Szczepankiewicz BG; Dai H; Koppetsch KJ; Qian D; Jiang F; Mao C; Perni RB
J Org Chem; 2012 Sep; 77(17):7319-29. PubMed ID: 22849721
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.
Avalos JL; Bever KM; Wolberger C
Mol Cell; 2005 Mar; 17(6):855-68. PubMed ID: 15780941
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the human deacylase Sirtuin 5 by the indole GW5074.
Suenkel B; Fischer F; Steegborn C
Bioorg Med Chem Lett; 2013 Jan; 23(1):143-6. PubMed ID: 23195732
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD(+)-dependent Sir2 histone/protein deacetylases.
Zhao K; Harshaw R; Chai X; Marmorstein R
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8563-8. PubMed ID: 15150415
[TBL] [Abstract][Full Text] [Related]
15. Ex-527 inhibits Sirtuins by exploiting their unique NAD+-dependent deacetylation mechanism.
Gertz M; Fischer F; Nguyen GT; Lakshminarasimhan M; Schutkowski M; Weyand M; Steegborn C
Proc Natl Acad Sci U S A; 2013 Jul; 110(30):E2772-81. PubMed ID: 23840057
[TBL] [Abstract][Full Text] [Related]
16. Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry.
Sauve AA; Schramm VL
Biochemistry; 2003 Aug; 42(31):9249-56. PubMed ID: 12899610
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial sirtuins.
Huang JY; Hirschey MD; Shimazu T; Ho L; Verdin E
Biochim Biophys Acta; 2010 Aug; 1804(8):1645-51. PubMed ID: 20060508
[TBL] [Abstract][Full Text] [Related]
18. Human sirtuins are differentially sensitive to inhibition by nitrosating agents and other cysteine oxidants.
Kalous KS; Wynia-Smith SL; Summers SB; Smith BC
J Biol Chem; 2020 Jun; 295(25):8524-8536. PubMed ID: 32371394
[TBL] [Abstract][Full Text] [Related]
19. Detecting sirtuin-catalyzed deacylation reactions using ³²P-labeled NAD and thin-layer chromatography.
Zhu A; Su X; Lin H
Methods Mol Biol; 2013; 1077():179-89. PubMed ID: 24014407
[TBL] [Abstract][Full Text] [Related]
20. Sirtuin 5: a review of structure, known inhibitors and clues for developing new inhibitors.
Yang L; Ma X; He Y; Yuan C; Chen Q; Li G; Chen X
Sci China Life Sci; 2017 Mar; 60(3):249-256. PubMed ID: 27858336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
